Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease is a research paper published in Cancer Discovery (2021). On theSindex it has a DataRank of 0. It has been cited 321 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: 5R25CA180993
Postdoctoral Research Fellowship
Grant: 134031-PF-19-164-01-TBG
Leukemia and Lymphoma Society NCI
Grant: R01CA257655
Leukemia and Lymphoma Society NCI
Grant: R01CA233975
Leukemia and Lymphoma Society NCI
Grant: R01CA188298
NCI
Grant: R01CA244526
NCI
Grant: R01CA254179
NCI NIH HHS
Grant: R25 CA180993
NCI NIH HHS
Grant: R01 CA233578
National Institutes of Health
Grant: 5R01CA257655-04
Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma
National Institutes of Health
Grant: 5R01CA188298-04
Noninvasive monitoring of lung cancer patients treated with radiotherapy
National Institutes of Health
Grant: 5R01CA244526-04
Analysis of urine tumor nucleic acids for detection and personalized surveillance of bladder cancer
National Institutes of Health
Grant: 5R25CA180993-02
Cancer Systems Biology Scholars Program
National Institutes of Health
Grant: 5R01CA254179-03
Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer
National Institutes of Health
Grant: 5R01CA233975-04
A Genomic Framework for Molecular Risk Prediction & Individualized Lymphoma Therapy
FWCI
16.23
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
Additional file 1 of Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
Additional file 2 of Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
Additional file 2 of Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
Additional file 3 of Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
Additional file 3 of Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
Additional file 1 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 1 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 3 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 3 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 4 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 4 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 7 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 7 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 8 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 8 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 9 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 9 of Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
Additional file 1 of Analyzing molecular typing and clinical application of immunogenic cell death-related genes in hepatocellular carcinoma
Additional file 1 of Analyzing molecular typing and clinical application of immunogenic cell death-related genes in hepatocellular carcinoma